Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Insight Molecular Diagnostics Inc. Director's Dealing 2016

Aug 30, 2016

34238_dirs_2016-08-30_8ed19b48-977e-4341-ac2d-59aacf5a4110.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OncoCyte Corp (OCX)
CIK: 0001642380
Period of Report: 2016-08-29

Reporting Person: BAILEY DON M (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 247001 Direct

Footnotes

F1: The shares are held by Mr. Bailey and his wife as co-trustees of a revocable trust, and in such capacity Mr. Bailey and his wife have shared voting and dispositive power over the shares.